Nav

Cancer and Chondrosarcoma

Request a Second Opinion

                                    
                                        Close-up photograph of a  microscope with a prepared slide clipped into the stage

How Do Chondrosarcomas Develop?

A chondrosarcoma is a rare cancer that begins in the cartilage cells of bones. These cells can become cancerous because of genetic mutations and divide uncontrollably to form a tumor. Some risk factors for chondrosarcoma have been identified, and these include age, exposure to radiation, and a family history of bone tumors.

Are Chondrosarcomas Bone Cancers?

Yes, a chondrosarcoma is a malignant bone cancer. The suffix -sarcoma usually refers to a malignant type of tumor. Thus, by definition, tumors such as chondrosarcoma and osteosarcoma are malignant. However, chondrosarcomas can behave differently with some being slower growing than others. They tend to occur in the bones of the hips, legs and arms. They can also occur at the base of the skull, in the tailbone, and in the spine. Although they are generally slow growing, they cause significant damage to nearby tissues and bones. They are also known to recur, making their treatment challenging.

Do Chondrosarcoma Bone Cancers Spread to the Rest of the Body?

Although rare, chondrosarcomas have been known to metastasize. Metastasis is the spread of cancer from the original (primary) site to other parts of the body. The cancer cells can spread through the body’s circulation system, including blood and lymphatics, and form new tumors in other organs or tissues. Chondrosarcoma metastases commonly occur in the lungs and bone.

It is important to remember that not all chondrosarcomas metastasize. The risk of metastasis depends on the size, location, grade, and subtype of the tumor. Early detection and treatment are important to improve the chances of controlling the spread of the tumor. Treatment of metastatic chondrosarcomas involves a combination of surgery, radiation therapy, and chemotherapy. The goal of treatment is to relieve symptoms and limit the progression of the tumor.

Why should you have your surgery with Dr. Cohen?

Dr. Cohen

  • 7,500+ specialized surgeries performed by your chosen surgeon
  • More personalized care
  • Extensive experience = higher success rate and quicker recovery times

Major Health Centers

  • No control over choosing the surgeon caring for you
  • One-size-fits-all care
  • Less specialization

For more reasons, please click here.

What Are the Grades of Chondrosarcoma?

Grading of a tumor is a way to determine how aggressive it is. It helps decide suitable treatment options and predict the outcome.

If your doctor suspects a chondrosarcoma, they will perform a biopsy, in which a small sample of the tumor is collected and examined under a microscope. The biopsy results will also include the grading of the tumor.

The World Health Organization (WHO) grading system is a commonly used system for classifying chondrosarcomas into 3 grades:

  • Grade I: This is the least aggressive type of chondrosarcoma and has the best prognosis. A grade I tumor typically grows slowly and is confined to the site of origin.
  • Grade II: This type of chondrosarcoma is moderately aggressive and has a more unpredictable behavior. A grade II tumor may recur locally or spread to the surrounding tissues.
  • Grade III: This is the most aggressive type of chondrosarcoma and has the least favorable prognosis. A grade III tumor tends to grow quickly and spread to other parts of the body, making it more difficult to treat.

Although important, the WHO grading system is not the only prognostic indicator. Other factors, such as the location of the tumor and the patient’s overall health, also affect the prognosis.

What Are the Stages of Chondrosarcomas?

The staging of chondrosarcoma is determined by the grade of the tumor, how invasive it is, and whether it has spread to other parts of the body. The most commonly used staging system is the Enneking staging system, which categorizes chondrosarcomas as follows:

  • Stage 1A: Low-grade tumor, located only within the vertebra, with no spread to other distant parts of the body.
  • Stage 1B: Low-grade tumor, invaded surrounding tissue, with no spread to other distant parts of the body.
  • Stage 2A: High-grade tumor, located only within the vertebra, with no spread to other distant parts of the body.
  • Stage 2B: High-grade tumor, invaded surrounding tissue, with no spread to other distant parts of the body.
  • Stage 3: Tumor has spread to other distant parts of the body.

The higher the stage, the more severe and aggressive the tumor is.

To determine the level of invasion of surrounding tissues, computed tomography (CT) and magnetic resonance imaging (MRI) scans of the chondrosarcoma are needed, whereas to discover spread to distant parts of the body, CT scans of the chest and abdomen prove useful. Positron emission tomography (PET) scans are essential to look for signs of metastases.

Key Takeaways

  • Chondrosarcomas develop from cartilage cells in the bone that divide uncontrollably to form a tumor.
  • Chondrosarcomas are rare bone cancers that are locally aggressive but rarely spread to distant organs and tissues.
  • The grade of the chondrosarcoma is determined by a biopsy and examination of the tumor sample under a microscope.
  • The stage of the chondrosarcoma is determined by the grade of the tumor, its invasion into surrounding bone and tissues, and its spread to distant parts of the body. The higher the stage, the more severe the tumor.

Resources

Real Patient Stories

Dr. Cohen is the best of the best of the best. I had a large tumor (42.85mm x 37.79mm) pressing against my brain. I was referred to Dr. Cohen, who reviewed my scans and gave me the peace of mind...

Show Full Review

Ramon A.

Dr. Cohen gave me my life back. It’s cliché, but the truest explanation of the amazing work he and his entire team did for me. He performed a very tricky Microvascular decompression of my...

Show Full Review

Michael S.

Dr. Cohen took care of my son who had an AVM (Arteriovenous Malformation). Dr. Cohen recommended surgical removal, which was not what neurosurgeons we had seen before recommended. It was a...

Show Full Review

Lisa S.

One of the Most Prominent Neurosurgeons in the World

Aaron Cohen-Gadol, MD

7,500+

Complex brain surgeries performed by a single surgeon—more than any other neurosurgeon in the United States.

40+

Novel surgical techniques pioneered that have inspired thousands of neurosurgeons to achieve technical excellence.

600+

Peer-reviewed publications in respected journals advancing the field of neurosurgery and patient outcomes.

100,000+

Lives influenced through innovative surgical care, education, and his foundational contributions to the field.

Meet Dr. Cohen-Gadol

Dr. Cohen-Gadol (Cohen) is one of the world’s most preeminent neurosurgeons and the president of ATLAS Institute of Brain and Spine. He specializes in the treatment of complex brain and spine tumors, including meningiomas, pituitary adenomas, gliomas, and acoustic neuromas, as well as arteriovenous and cavernous malformations, hemifacial spasm, and trigeminal neuralgia. Neurosurgeons and patients both frequently seek his expert second opinion. Throughout his career, he has demonstrated a profound commitment and passion for pushing the boundaries of uncompromising excellence for his patients.

Professional Affiliations

Address

8631 W. 3rd Street, Suite 815E
Los Angeles, CA 90048

Opening Hours

Mon - Fri, 9:00 a.m. - 5:00 p.m

In Person Second Opinion Virtual Call

Copyright © 2025 Aaron Cohen-Gadol. All Rights Reserved.